Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors
Xiangdong Lv(National University of Defense Technology), Xi Chen(Baylor College of Medicine)
Cited by 103
Related Papers
Protein Kinase C α Is a Central Signaling Node and Therapeutic Target for Breast Cancer Stem Cells
|Cancer Cell|2013|320
TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer
|Cancer Informatics|2012|303
Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer
|Journal of Clinical Investigation|2018|260
Iron-dependent histone 3 lysine 9 demethylation controls B cell proliferation and humoral immune responses
|Nature Communications|2019|224